Cardiome Pharma (CRME) Dips on Q2 Loss

Cardiome Pharma Corp.

shares dipped 0.5% to $9.27, on recording a second-quarter net loss of $7.4 million, compared to a net loss of $4.2 million (loss per share of $0.26) for the three months ended June 30, 2014. Share volume was 27,000